121 related articles for article (PubMed ID: 36813234)
1. Expression of GnT-III decreases chemoresistance via negatively regulating P-glycoprotein expression: Involvement of the TNFR2-NF-κB signaling pathway.
Song W; Liang C; Sun Y; Morii S; Yomogida S; Isaji T; Fukuda T; Hang Q; Hara A; Nakano M; Gu J
J Biol Chem; 2023 Apr; 299(4):103051. PubMed ID: 36813234
[TBL] [Abstract][Full Text] [Related]
2. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
3. N-Glycosylation of laminin-332 regulates its biological functions. A novel function of the bisecting GlcNAc.
Kariya Y; Kato R; Itoh S; Fukuda T; Shibukawa Y; Sanzen N; Sekiguchi K; Wada Y; Kawasaki N; Gu J
J Biol Chem; 2008 Nov; 283(48):33036-45. PubMed ID: 18812317
[TBL] [Abstract][Full Text] [Related]
4. Cell-cell interaction-dependent regulation of N-acetylglucosaminyltransferase III and the bisected N-glycans in GE11 epithelial cells. Involvement of E-cadherin-mediated cell adhesion.
Iijima J; Zhao Y; Isaji T; Kameyama A; Nakaya S; Wang X; Ihara H; Cheng X; Nakagawa T; Miyoshi E; Kondo A; Narimatsu H; Taniguchi N; Gu J
J Biol Chem; 2006 May; 281(19):13038-13046. PubMed ID: 16537539
[TBL] [Abstract][Full Text] [Related]
5. Both internalization and AIP1 association are required for tumor necrosis factor receptor 2-mediated JNK signaling.
Ji W; Li Y; Wan T; Wang J; Zhang H; Chen H; Min W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2271-9. PubMed ID: 22743059
[TBL] [Abstract][Full Text] [Related]
6. Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway.
Yang L; Zhang C; Chen J; Zhang S; Pan G; Xin Y; Lin L; You Z
Pharm Biol; 2020 Dec; 58(1):276-285. PubMed ID: 32251615
[No Abstract] [Full Text] [Related]
7. [Effect of Bmi-1 on Multidrug Resistance in K562/ADR Cells and Its Mechanisms].
Zhao BX; Liu SQ; Dong SC; Jing RN; Meng XX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):758-766. PubMed ID: 32552933
[TBL] [Abstract][Full Text] [Related]
8. The glycomic effect of N-acetylglucosaminyltransferase III overexpression in metastatic melanoma cells. GnT-III modifies highly branched N-glycans.
Link-Lenczowski P; Bubka M; Balog CIA; Koeleman CAM; Butters TD; Wuhrer M; Lityńska A
Glycoconj J; 2018 Apr; 35(2):217-231. PubMed ID: 29502191
[TBL] [Abstract][Full Text] [Related]
9. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.
Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G
J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846
[TBL] [Abstract][Full Text] [Related]
10. Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition.
Wang L; Meng Q; Wang C; Liu Q; Peng J; Huo X; Sun H; Ma X; Liu K
J Nat Prod; 2013 May; 76(5):909-14. PubMed ID: 23621869
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of N-acetylglucosaminyltransferase III disrupts the tyrosine phosphorylation of Trk with resultant signaling dysfunction in PC12 cells treated with nerve growth factor.
Ihara Y; Sakamoto Y; Mihara M; Shimizu K; Taniguchi N
J Biol Chem; 1997 Apr; 272(15):9629-34. PubMed ID: 9092490
[TBL] [Abstract][Full Text] [Related]
12. Epifriedelanol enhances adriamycin-induced cytotoxicity towards K562/ADM cells by down regulating of P-gp and MRP2.
Li Y; Liao Z; Wei X; Xiao X; Hu J
Xenobiotica; 2022 Apr; 52(4):389-396. PubMed ID: 35582915
[TBL] [Abstract][Full Text] [Related]
13. Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation.
Kim HG; Hien TT; Han EH; Hwang YP; Choi JH; Kang KW; Kwon KI; Kim BH; Kim SK; Song GY; Jeong TC; Jeong HG
Br J Pharmacol; 2011 Mar; 162(5):1096-108. PubMed ID: 21054339
[TBL] [Abstract][Full Text] [Related]
14. Wnt/beta-catenin signaling down-regulates N-acetylglucosaminyltransferase III expression: the implications of two mutually exclusive pathways for regulation.
Xu Q; Akama R; Isaji T; Lu Y; Hashimoto H; Kariya Y; Fukuda T; Du Y; Gu J
J Biol Chem; 2011 Feb; 286(6):4310-8. PubMed ID: 21115490
[TBL] [Abstract][Full Text] [Related]
15. An N-glycosylation site on the beta-propeller domain of the integrin alpha5 subunit plays key roles in both its function and site-specific modification by beta1,4-N-acetylglucosaminyltransferase III.
Sato Y; Isaji T; Tajiri M; Yoshida-Yamamoto S; Yoshinaka T; Somehara T; Fukuda T; Wada Y; Gu J
J Biol Chem; 2009 May; 284(18):11873-81. PubMed ID: 19276077
[TBL] [Abstract][Full Text] [Related]
16. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
[TBL] [Abstract][Full Text] [Related]
17. Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription.
Shen H; Xu W; Chen Q; Wu Z; Tang H; Wang F
J Cancer Res Clin Oncol; 2010 May; 136(5):659-65. PubMed ID: 19898868
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of N-acetylglucosaminyltransferases III and V in human melanoma cells. Implications for MCAM N-glycosylation.
Bubka M; Link-Lenczowski P; Janik M; Pocheć E; Lityńska A
Biochimie; 2014 Aug; 103():37-49. PubMed ID: 24726881
[TBL] [Abstract][Full Text] [Related]
19. Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines.
Meesungnoen J; Jay-Gerin JP; Mankhetkorn S
Can J Physiol Pharmacol; 2002 Nov; 80(11):1054-63. PubMed ID: 12489924
[TBL] [Abstract][Full Text] [Related]
20. Introduction of bisecting GlcNAc in N-glycans of adenylyl cyclase III enhances its activity.
Li W; Takahashi M; Shibukawa Y; Yokoe S; Gu J; Miyoshi E; Honke K; Ikeda Y; Taniguchi N
Glycobiology; 2007 Jun; 17(6):655-62. PubMed ID: 17324955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
